These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31428580)

  • 21. The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.
    Lee SL; Bassetti MF; Rusthoven CG
    Semin Radiat Oncol; 2023 Apr; 33(2):181-192. PubMed ID: 36990635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Evolving Interplay of SBRT and the Immune System, along with Future Directions in the Field.
    Miljanic M; Montalvo S; Aliru M; Song T; Leon-Camarena M; Innella K; Vujovic D; Komaki R; Iyengar P
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
    Folkert MR; Timmerman RD
    Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total ablative stereotactic body radiotherapy to primary and oligometastatic renal cell carcinoma in medically inoperable cases: An institutional analysis.
    Bisht SS; Kataria T; Shishak S; Gupta D; Kaliyaperumal V; Wadhwa J; Suryavanshi M; Banerjee S; Narang K; Goyal S; Rathi D; Mayank M; Selvaraj R; Khandelwal A
    Indian J Urol; 2023; 39(4):303-310. PubMed ID: 38077208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
    Kent CL; McDuff SGR; Salama JK
    Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.
    Ricardi U; Badellino S; Filippi AR
    J Radiat Res; 2016 Aug; 57(S1):i58-i68. PubMed ID: 26962198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done.
    Bartl AJ; Mahoney M; Hennon MW; Yendamuri S; Videtic GMM; Stephans KL; Siva S; Farrugia MK; Ma SJ; Singh AK
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview.
    Zeng KL; Tseng CL; Soliman H; Weiss Y; Sahgal A; Myrehaug S
    Front Oncol; 2019; 9():337. PubMed ID: 31119099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic Body Radiotherapy - Current Indications.
    Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
    Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial.
    Zhao X; Wang T; Ye Y; Li J; Gao X; Zhang H
    BMJ Open; 2022 Sep; 12(9):e051371. PubMed ID: 36180115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China.
    Xu C; Zhao X; Ju X; Shen Y; Qu M; Ye Y; Wang X; Yu C; Gao X; Zhang H
    Front Oncol; 2022; 12():879310. PubMed ID: 35574331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease.
    Dohopolski MJ; Horne Z; Clump D; Burton SA; Heron DE
    Cureus; 2018 Feb; 10(2):e2167. PubMed ID: 29644155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiation therapy for oligometastases.
    Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
    Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligometastatic non-small cell lung cancer: Current management.
    Román-Jobacho A; Hernández-Miguel M; García-Anaya MJ; Gómez-Millán J; Medina-Carmona JA; Otero-Romero A
    J Clin Transl Res; 2021 Jun; 7(3):311-319. PubMed ID: 34239990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept.
    Hao C; Liu J; Ladbury C; Dorff T; Sampath S; Pal S; Dandapani S
    Cancer Treat Res Commun; 2023; 35():100692. PubMed ID: 36842365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma.
    Vorbach SM; Mangesius J; Dejaco D; Seppi T; Santer M; Zur Nedden S; Sarcletti MP; Pointner MJ; Hart TJ; Riechelmann H; Ganswindt U; Nevinny-Stickel M
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
    Bouman-Wammes EW; van Dodewaard-De Jong JM; Dahele M; Cysouw MCF; Hoekstra OS; van Moorselaar RJA; Piet MAH; Verberne HJ; Bins AD; Verheul HMW; Slotman BJ; Oprea-Lager DE; Van den Eertwegh AJM
    Clin Genitourin Cancer; 2017 Oct; 15(5):e773-e782. PubMed ID: 28462855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.